London Genetics Ltd expedites partnerships between the biopharmaceutical industry and London-based centres of excellence in genetic research

Pharmacogenetics will play a key role in the future of drug development and healthcare delivery, with the biopharmaceutical industry coming under increasing pressure for greater innovation, productivity and safety. By providing companies with access to the combined genetics expertise and  resources of its seven academic institution partners, London Genetics Ltd can help them meet these challenges. The company has broad expertise  across a range of therapeutic areas, with a focus on cardiovascular disease and cardiovascular safety.  It is based at the Imperial College Incubator in London, UK.

London Genetics provides unique access to:

• Comprehensive patient cohorts, clinical data, samples and genetic information
• Ethnically diverse populations
• Key opinion leaders
• Investigator-led collaborative research programmes
• Strategic consultancy
• DNA/RNA analysis and bioinformatics services